海外の治験の状況「1」での検索結果
65件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Available
- Clinical trial to evaluate the effectiveness and safety of IFN beta-1a (IFN beta-1a), injected once a week via intramuscolar (i.m.), and glatiramer-acetate (GA) in children/adolescent patients with multiple sclerosis.
- Relapsing-remitting multiple sclerosis with paediatric onset MedDRA version: 20.1 Level: PT Classification code 10028245 Term: Multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Italy
- 2018-03-26
Not Available
- A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in ß-thalassemia Major Pediatric Patients With Transfusional Iron Overload.
- MedDRA version: 19.0 Level: LLT Classification code 10054661 Term: Thalassemia major System Organ Class: 100000004850 MedDRA version: 19.0 Level: LLT Classification code 10054660 Term: Thalassemia beta System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- France, Italy
- 2016-03-08
Not Available
- A study to investigate a new medication, NI-0501, in children with the disease systemic Juvenile Idiopathic Arthritis (sJIA) developing Macrophage Activation Syndrome/secondary Hemophagocytic Lymphohistiocytosis (MAS/sHLH)
- Macrophage activation syndrome / Secondary hemophagocytic lymphohistiocytosis (MAS/sHLH) in patients with Systemic Juvenile Idiopathic Arthritis (sJIA) MedDRA version: 20.0 Level: LLT Classification code 10053867 Term: Macrophage activation syndrome System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Canada, France, Italy, Netherlands, Spain, United Kingdom, United States
- 2017-02-13
Not Available
- Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Crohn’s Disease, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo.
- Crohn's disease MedDRA version: 20.0 Level: LLT Classification code 10011402 Term: Crohn's disease (colon) System Organ Class: 100000004856 ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
- 2018-04-10
Not Available
- Nasopharyngeal pneumococcal colonization data in infants at the age of 12, 18 and 24 months - Pneumococcal carriage in infants
- Pneumococcal carriership in children having previously received Prevenar vaccination (7-valent pneumococcal conjugate vaccine) according to the 3+1 vaccination schedule used in the Dutch National Immunization Program (NIP). Comparison will be done to the 2+1 schedule group of the MINOES trial (ISRCNTN25571720).
- Netherlands
- 2008-05-30
Not Available
- A Phase 1/2 clinical trial of the drug Quizartinib (AC220) to investigate the safety and efficacy in paediatric patients (aged 1 month to <18 years) and young adults (aged up to 21 years) with Acute Myeloid Leukemia (AML), a cancer of the blood.
- Relapsed or Refractory acute myeloid leukemia (AML) in subjects aged =1 month to =21 years with FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) mutations following failure of front-line intensive chemotherapy br>MedDRA version: 20.0 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10060558 Term: Acute myeloid leukemia recurrent System Organ Class: 100000004864 MedDRA version: 20.1 Level: PT Classification code 10076230 Term: Fms-like tyrosine kinase 3 positive System Organ Class: 10022891 - Investigations ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
- 2018-02-20
Not Available
- A Phase 1/2 clinical trial of the drug Quizartinib (AC220) to investigate the safety and efficacy in paediatric patients (aged 1 month to <18 years) and young adults (aged up to 21 years) with Acute Myeloid Leukemia (AML), a cancer of the blood.
- Relapsed or Refractory acute myeloid leukemia (AML) in subjects aged =1 month to =21 years with FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) mutations following failure of front-line intensive chemotherapy br>MedDRA version: 20.0 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10060558 Term: Acute myeloid leukemia recurrent System Organ Class: 100000004864 MedDRA version: 20.1 Level: PT Classification code 10076230 Term: Fms-like tyrosine kinase 3 positive System Organ Class: 10022891 - Investigations ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
- 2018-03-26
Not Available
- A multi-centre, single-blind, parallel group, clinical evaluation of the efficacy and safety of clindamycin 1% / benzoyl peroxide 3% and azelaic acid 20% in the topical treatment of mild to moderate acne vulgaris
- Acne Vulgaris MedDRA version: 20.0 Level: LLT Classification code 10000519 Term: Acne vulgaris System Organ Class: 100000018399 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Germany
- 2017-09-21
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-06-06
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, United Kingdom, United States
- 2018-05-29
